Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Kober

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Circulation. Heart Failure|October 22, 2013
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failureHelle Bosselmann, Gunnar Gislason, Finn Gustafsson, et al.
European Journal of Heart Failure|May 3, 2024
Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort studyDeewa Zahir Anjum, Jarl E Strange, Emil Fosbøl, et al.
The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
Shock (Augusta, Ga.)|April 12, 2019
Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock StudyMatias Greve Lindholm, Mari Hongisto, Johan Lassus, et al.
Clinical Pharmacology in Drug Development|November 20, 2018
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 TrialHans-Dirk Düngen, Lars Kober, Savina Nodari, et al.
European Journal of Preventive Cardiology|January 9, 2014
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide studySumeet Subherwal, Manesh R Patel, Lars Kober, et al.
European Journal of Heart Failure|December 30, 2021
Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017Deewa Zahir, Anders Bonde, Christian Madelaire, et al.
Journal of the American Heart Association|November 1, 2021
Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide StudyMagnus N Ebbesen, Maria D'Souza, Charlotte Andersson, et al.
Clinical Epidemiology|July 25, 2023
Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide StudyDeewa Zahir Anjum, Jarl Emanuel Strange, Emil Fosbøl, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Circulation. Heart Failure|October 22, 2013
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failureHelle Bosselmann, Gunnar Gislason, Finn Gustafsson, et al.
European Journal of Heart Failure|May 3, 2024
Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort studyDeewa Zahir Anjum, Jarl E Strange, Emil Fosbøl, et al.
The American Journal of Cardiology|March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
Shock (Augusta, Ga.)|April 12, 2019
Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock StudyMatias Greve Lindholm, Mari Hongisto, Johan Lassus, et al.
Clinical Pharmacology in Drug Development|November 20, 2018
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 TrialHans-Dirk Düngen, Lars Kober, Savina Nodari, et al.
European Journal of Preventive Cardiology|January 9, 2014
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide studySumeet Subherwal, Manesh R Patel, Lars Kober, et al.
European Journal of Heart Failure|December 30, 2021
Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017Deewa Zahir, Anders Bonde, Christian Madelaire, et al.
Journal of the American Heart Association|November 1, 2021
Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide StudyMagnus N Ebbesen, Maria D'Souza, Charlotte Andersson, et al.
Clinical Epidemiology|July 25, 2023
Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide StudyDeewa Zahir Anjum, Jarl Emanuel Strange, Emil Fosbøl, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Pageof 11